Morgan Stanley Leads Investment in AI-driven Cardiac Device
Octagos Health, an AI-driven cardiac device monitoring provider, has secured over $43 million in a Series B investment led by Morgan Stanley Expansion Capital, with continued support from Mucker Capital and other investors. This funding will enhance their AI platform, Atlas AI, which offers continuous monitoring and data analysis for various cardiac devices. The platform integrates seamlessly with electronic health records (EHR) and provides customizable reports, aiming to improve patient outcomes and automate physician workflows, making it a preferred choice for cardiology practices.
Morgan Stanley Leads Investment in AI-driven Cardiac Device